Introduction. To date, few studies have investigated the specific neurological manifestations of SARS-CoV-2 infection in children. The studies reported prevalences from 3.8% to 44% of neurologic involvement in children with SARS-CoV-2. The aim: to study the type of neurological manifestations in children with SARS-CoV-2 infection. Material and Methods. I analyzed prospectively the patients with neurological manifestations associated with SARS-CoV-2 infection, aged from one month to 5 years, at Institute for Mother and Child. I divided these manifestations according to their type: specific and non-specific. I have used neurological testing, laboratory tests, and imaging investigations: electroencephalography evaluation (EEG). Statistic processing: t-student test and the confidence index 95 C. Results. Of the 138 hospitalized children with confirmed SARS-CoV-2 – only 46 cases (33,3%; 95CI 37,3129,29) were reported with neurological manifestations. Of these, 26 children (56.5%; 95CI63.81-49.19) had specific neurological manifestations, including toxic-infectious encephalopathy 21 (45.7%; 95CI 38.36-53.04) cases, seizures – 3 (6.5%; 95CI 2.86-10.14), myositis – 2 (4.3%; 95CI 1.29-7.31), and 20 (43.5%; 95CI 36.19-50.81) cases presented non-specific neurological manifestations: fatigue – 13 (28.3%; 95CI 21.66-34.94) cases, headaches – 5 (10.9%; 95CI 6.31-15.49) and anosmia/ageusia – 2 (4.3%; 95CI 1,29-7.31) cases. Conclusions. Although most studies have demonstrated the predominance of non-specific neurological manifestations, the results obtained in this study tell us that children with SARS-CoV-2 infection are at risk of developing specific neurological manifestations such as toxic-infectious encephalopathy and seizures.